RxDoctor Payments Data

Janelle Martinez

Family · Tacoma, WANPI 1285293266

Payments from drug & device makers

$464in general payments, 2019–2025

Across 18 payments — averaging $25.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Actelion Pharmaceuticals US, Inc.$74
  • Abbott$72
  • Alnylam Pharmaceuticals Inc.$61
  • Impulse Dynamics (USA) Inc.$49
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$48
  • Merck$48
  • plus $113 from 5 others

What the payments were for

  • Food & beverage$464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$464 in reported general payments places this provider in the 70th percentile of 1,706 family providers in Washington.

See all family providers in Washington

Medicare billing

Part B allowed, 2024
$20,462
Medicare patients
102
Services billed
204

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan106$134,332
JardianceEmpagliflozin99$129,824
EliquisApixaban78$95,564
XareltoRivaroxaban31$34,940
FarxigaDapagliflozin Propanediol27$31,099
Torsemide99$2,702
Metoprolol Succinate132$1,309
Eplerenone18$751
Spironolactone115$651
Rosuvastatin Calcium24$581
Atorvastatin Calcium65$519
Midodrine Hcl13$362
Furosemide62$238
Carvedilol39$228
Isosorbide Mononitrate ErIsosorbide Mononitrate16$157

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$95,56478 claims
AstraZenecaFarxiga$22$31,09927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,706 family providers in Washington.

Other family in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →